Results 231 to 240 of about 115,341 (318)

Impact of Neoadjuvant Induction Chemotherapy Prior to Chemoradiation on Survival and Surgical Outcomes in Real-World Esophageal Adenocarcinoma Cohort. [PDF]

Cancers (Basel)
Matoska TM, Memon AA, Acevedo Moreno LA, Bulacan C, Rein L, Banerjee A, George B, Jurkowski L, Phan A, Johnstone C, Shukla ME, Gore EM, Linsky P, Gasparri M, Hunt M, Puckett LL.   +15 more
europepmc   +1 more source

Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum [PDF]

, 2008
Arman Kilic, Matthew J. Schuchert, James D. Luketich, Rodney J. Landreneau, Anna Lokshin, William L. Bigbee, Talal El‐Hefnawy   +6 more
openalex   +1 more source

RNA‐Binding Proteins and Ferroptosis in Cancer: Mechanism and Therapeutic Implications

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Ferroptosis critically influences cancer cell fate and represents a promising therapeutic strategy. Emerging evidence identifies RNA‐binding proteins (RBPs) as key post‐transcriptional regulators of ferroptosis. The figure summarizes ferroptosis‐related RBPs across cancers: blue RBPs act as tumor suppressors by promoting ferroptosis, whereas red RBPs ...
Linlin Chang, Bin Lu, Haotian Shang, Wanjing Ding, Chunhua Wei, Xiaotian Qi, Pengxing He   +6 more
wiley   +1 more source

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis. [PDF]

Mol Oncol
García-Castillo J, Martínez-Cáceres CM, Bernabé-García M, Munitiz V, Ruiz de Angulo D, Parrilla P, Ortiz Á, Martínez de Haro LF, Cayuela ML.   +8 more
europepmc   +1 more source

Endoscopic Therapy for Barrett's Esophagus and Early Esophageal Adenocarcinoma

, 2013
Cadman L. Leggett, Emmanuel C. Gorospe, Kenneth K. Wang   +2 more
openalex   +2 more sources

Aging‐Derived Alterations in Genomic, Immune, and Metabolic Networks: Implications for Cancer Development and Therapy

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang, Xue Sun, Xinhao Han, Xingda Zhang, Wenzheng Wang, Hongbin Wang, He Ren, Lina Gu   +7 more
wiley   +1 more source

No significant link found between Helicobacter pylori serological antibodies and the development of esophageal adenocarcinoma. [PDF]

Discov Oncol
Tang J, Wei S, Zhou Y, Li Y, Zhao P.
europepmc   +1 more source

Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors

International Journal of Cancer, Volume 158, Issue 4, Page 1093-1105, 15 February 2026.
What's new? Tumor matrix stiffness plays a critical role in cancer progression, metastasis, and therapy resistance. Here, the authors leveraged tumor RNA‐seq data to identify molecular signatures of mechanical properties across various cancer types and build a computational model for predicting tumor matrix stiffness.
Gongyu Tang, Xinyi Liu, Yuanxiang Li, Yunfei Ta, Minsu Cho, Hua Li, Xiaowei Wang   +6 more
wiley   +1 more source

Post-endoscopy esophageal adenocarcinoma and root cause analysis in Auckland, New Zealand. [PDF]

Endosc Int Open
Shin S, Kang D, Walmsley RS.
europepmc   +1 more source

Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma

Benjamin P. Sharpe, Liliya Nazlamova, Carmen Tse, David A. Johnston, Jaya Thomas, Rhianna R R Blyth, Oliver Pickering, Ben Grace, Jack Harrington, Rushda Rajak, Matthew Rose‐Zerilli, Zoë S. Walters, Tim Underwood   +12 more
openalex   +1 more source